Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.25%
1,104.10
+2.73
+0.25%
1,101.371,103.631,105.311,091.41
SIXC
Communications
SIXC
Communications
SIXC
-1.50%
604.16
-9.19
-1.50%
613.35613.35613.35601.49
SIXE
Energy
SIXE
Energy
SIXE
-0.09%
1,197.81
-1.02
-0.09%
1,198.831,199.681,199.751,182.41
SIXI
Industrials
SIXI
Industrials
SIXI
-0.88%
1,740.41
-15.54
-0.88%
1,755.951,754.061,756.031,734.69
SIXM
Financials
SIXM
Financials
SIXM
-0.64%
634.44
-4.07
-0.64%
638.51637.41637.41633.05
SIXR
Staples
SIXR
Staples
SIXR
-0.31%
840.90
-2.62
-0.31%
843.52843.35846.40837.93
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.38%
215.13
-0.82
-0.38%
215.95215.95216.84215.06
SIXT
Technology
SIXT
Technology
SIXT
+2.86%
3,228.71
+89.80
+2.86%
3,138.913,189.303,230.853,174.76
SIXU
Utilities
SIXU
Utilities
SIXU
+0.16%
935.87
+1.50
+0.16%
934.37934.72938.26927.50
SIXV
Health care
SIXV
Health care
SIXV
-1.37%
1,457.12
-20.31
-1.37%
1,477.431,474.121,474.121,451.80
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.83%
2,399.84
+19.65
+0.83%
2,380.192,389.342,403.042,380.47
214390:KRX
Kyongbo Pharmaceutical Co Ltd
₩6,820.00
0.00%
(0.00) 1D
Apr 24, 3:30:22 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 214390...
Open
₩6,890
High
₩6,890
Low
₩6,630
Mkt. cap
163.04B
Avg. vol.
2.09M
Volume
64.77K
Dividend
0.73%
Quarterly dividend
₩13
Ex dividend date
Dec 29, 2025
P/E ratio
894.41
52-wk high
₩9,300
52-wk low
₩4,755
EPS
₩8
Shares outstanding
23.91M
No. of employees
568
News stories
From sources across the web
About Kyongbo Pharmaceutical Co Ltd
CEOKim Tae-young
Employees568
Founded1987
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
60.59B
65.31B
66.99B
71.22B
Cost of goods sold
36.53B
38.42B
42.39B
44.46B
Cost of revenue
36.53B
38.42B
42.39B
44.46B
Research and development expenses
4.77B
4.43B
4.46B
4.50B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
18.52B
19.32B
18.88B
20.67B
Operating expense
23.94B
24.49B
24.12B
26.24B
Total operating expenses
60.47B
62.91B
66.51B
70.70B
Operating income
121.22M
2.41B
474.48M
515.50M
Other non operating income
-1.07B
-3.41B
-1.10B
2.51B
EBT including unusual items
-971.86M
-1.03B
3.44B
-995.05M
EBT excluding unusual items
-971.86M
-1.03B
3.44B
-857.95M
Income tax expense
-287.35M
704.68M
412.26M
-562.40M
Effective tax rate
29.57%
-68.56%
11.97%
56.52%
Other operating expenses
191.32M
174.39M
194.62M
276.72M
Net income
-684.52M
-1.73B
3.03B
-432.65M
Net profit margin
-1.13%
-2.65%
4.53%
-0.61%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
41.30M
Interest expense
-
-
-
-4.29B
Net interest expenses
-
-
-
-4.25B
Depreciation and amortization charges
568.19M
146.67M
377.69M
385.22M
EBITDA
3.26B
5.65B
3.86B
3.95B
Gain or loss from assets sale
167.50M
-12.00M
-6.40M
10.00K
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more